aim
evalu
contribut
multiplex
pcr
respiratori
virus
antibiot
antivir
prescript
ancillari
test
prescript
admiss
length
stay
patient
method
two
hundr
ninetyon
adult
pediatr
patient
visit
emerg
depart
influenza
epidem
prospect
includ
immedi
test
use
filmarray
respiratori
panel
result
commun
practition
charg
soon
becam
avail
clinic
biolog
data
gather
analyz
find
result
filmarray
respiratori
panel
appear
impact
admiss
antibiot
prescript
except
lower
admiss
rate
children
test
posit
influenza
b
paramet
account
clinic
decis
evalu
crp
level
white
blood
cell
count
suspect
proven
bacteri
infect
adult
patient
sign
respiratori
distress
length
stay
also
significantli
differ
patient
posit
neg
result
rapid
influenza
test
result
permit
appropri
prescript
oseltamivir
multiplex
molecular
techniqu
respiratori
viru
detect
alreadi
shown
benefit
term
sensit
gain
greater
rang
detect
pathogen
comparison
convent
techniqu
recent
progress
made
possibl
shorten
turnaround
time
tat
allow
deliveri
result
time
manner
especi
comparison
cell
cultur
direct
fluoresc
assay
dfa
hodinka
kaiser
xu
et
al
zumla
et
al
howev
molecular
techniqu
clearli
shown
costeffect
studi
report
conflict
result
possibl
due
differ
studi
design
seem
agre
upon
result
molecular
test
deliv
rapidli
cours
patient
manag
avail
result
emerg
room
er
would
like
help
avoid
antibiot
use
ancillari
test
prescript
improv
antivir
prescript
shorten
length
stay
ward
facilit
discharg
patient
cohort
hospit
patient
name
influenza
virus
xu
et
al
rappo
et
al
busson
et
al
select
popul
test
appli
also
seem
great
import
increas
costeffect
boeckh
renaud
shed
light
import
issu
report
result
prospect
intervent
studi
includ
select
adult
pediatr
patient
visit
emerg
depart
tertiari
care
hospit
saintpierr
brussel
influenza
epidem
patient
immedi
test
standard
care
filmarray
fa
respiratori
panel
marci
letoil
franc
evalu
outcom
antibiot
antivir
prescript
admiss
length
stay
hospit
patient
prescript
ancillari
test
patient
isol
studi
took
place
februari
week
march
week
saintpierr
univers
hospit
tertiari
care
hospit
brussel
influenza
season
belgium
moder
last
week
week
influenza
isol
collect
belgium
regard
influenza
b
circul
strain
almost
exclus
victoria
lineag
accord
belgian
public
health
institut
adult
children
visit
emerg
room
present
upper
lower
respiratori
symptom
prospect
includ
either
expect
hospit
follow
condit
chronic
respiratori
diseas
cystic
fibrosi
asthma
chronic
obstruct
pulmonari
diseas
sicklecel
diseas
asplenia
neuromuscular
diseas
sever
neurolog
impair
hereditari
metabol
disord
includ
diabet
congenit
acquir
immunosuppress
heart
defect
chronic
nephropathi
chronic
liver
diseas
pregnanc
children
month
age
fever
without
focu
fwf
also
includ
upon
inclus
patient
respiratori
sampl
collect
usual
nasopharyng
aspir
npa
children
year
nasopharyng
swab
np
flock
swab
utm
ml
copan
brescia
itali
older
children
adult
sampl
sent
microbiolog
laboratori
accompani
form
practition
note
intent
concern
manag
patient
hospit
isol
prescript
antibiot
antivir
treatment
ancillari
test
sampl
immedi
analyz
filmarray
respiratori
panel
result
commun
soon
avail
practition
charg
patient
data
collect
concern
chang
manag
patient
paramet
note
form
previous
sent
lab
sampl
paramet
collect
patient
file
filmarray
respiratori
panel
fulli
autom
multiplex
pcr
techniqu
short
handson
time
min
detect
viral
target
adenoviru
coronavirus
influenza
distinct
influenza
b
human
metapneumoviru
parainfluenza
human
rhinovirusenteroviru
without
distinct
two
respiratori
syncyti
viru
rsv
bacteri
target
mycoplasma
pneumonia
chlamydophila
pneumonia
bordetella
pertussi
test
perform
one
time
analyz
filmarray
system
approxim
one
hour
test
npa
dilut
ml
viral
transport
medium
compos
veal
infus
broth
difco
becton
dickinson
spark
md
usa
supplement
bovin
albumin
sigmaaldrich
st
loui
mo
usa
test
perform
use
ml
dilut
sampl
continu
variabl
compar
group
student
ttest
nomin
variabl
pearson
chisquar
test
correct
age
perform
use
binari
logist
regress
age
significantli
differ
compar
group
softwar
use
ibmspss
ncss
adult
statist
analys
virus
perform
preval
virus
name
influenza
influenza
b
rhinoenterovirus
pvalu
consid
signific
total
sampl
patient
analyz
sampl
obtain
children
year
old
femal
male
mean
age
year
old
median
age
month
sampl
obtain
adult
year
old
femal
male
mean
age
year
old
median
age
characterist
popul
detail
tabl
sampl
compos
npa
np
detect
pathogen
list
tabl
one
hundr
twentyf
sampl
children
sampl
adult
posit
accord
fa
mean
turnaround
time
deliv
result
h
visit
pediatr
er
discharg
hospit
children
significantli
younger
nonhospit
children
vs
year
p
due
signific
differ
median
age
differ
group
correct
age
perform
use
binari
logist
regress
order
mitig
influenc
age
calcul
result
statist
analys
tabl
signific
pvalu
note
bold
charact
result
limit
signific
underlin
focu
critic
popul
patient
hospit
examin
intent
hospit
report
form
attach
sampl
exclud
analysi
remain
subset
n
split
patient
effect
hospit
n
discharg
er
examin
n
abovement
paramet
compar
two
group
determin
could
util
decis
discharg
admit
mean
age
significantli
lower
hospit
patient
vs
year
p
correct
age
perform
tabl
data
avail
length
stay
hospit
children
compar
group
patient
posit
fa
result
n
group
neg
result
n
hypothesi
posit
result
earli
cours
patient
manag
could
shorten
length
stay
mean
age
two
group
significantli
differ
year
group
posit
result
vs
year
group
neg
result
p
mean
length
stay
significantli
differ
two
group
day
group
posit
fa
result
vs
day
group
neg
fa
result
p
abovement
paramet
compar
group
children
receiv
antibiot
n
receiv
antibiot
n
patient
intent
antibiot
prescript
receiv
antibiot
avail
test
result
exclud
remain
subset
separ
two
group
depend
whether
patient
inde
receiv
antibiot
n
n
paramet
compar
two
group
tabl
patient
isol
polici
regard
children
impli
everi
child
suspect
confirm
infecti
diseas
respiratori
isol
includ
children
suspect
infecti
diseas
posit
fa
result
chang
decis
isol
patient
moreov
isol
avoid
base
neg
result
neg
fa
result
rule
everi
infecti
caus
children
neg
fa
result
patient
fever
undetermin
origin
patient
urinari
tract
infect
one
patient
measl
one
patient
scarlet
fever
one
patient
rotaviru
infect
one
patient
bacteri
bronchopneumonia
one
patient
cutan
infect
patient
diagnosi
noninfecti
diseas
condit
requir
isol
usual
maintain
confirm
obtain
longer
necessari
compar
group
hospit
patient
n
discharg
patient
n
mean
age
significantli
higher
hospit
patient
correct
age
perform
statist
analys
result
intabl
signific
pvalu
bold
charact
pvalu
limit
signific
underlin
subset
patient
hospit
intend
institut
test
result
receiv
exclud
focu
critic
popul
remain
subset
n
split
group
patient
inde
hospit
n
discharg
er
n
group
significantli
differ
age
hospit
patient
older
vs
year
p
correct
age
perform
statist
analys
tabl
data
avail
length
stay
hospit
patient
compar
group
posit
filmarrray
result
n
group
neg
result
n
mean
age
differ
two
group
year
group
posit
result
vs
year
group
neg
result
p
correct
age
appli
even
though
length
stay
longer
fa
result
neg
vs
day
appar
differ
limit
signific
correct
age
p
group
patient
receiv
antibiot
n
compar
group
receiv
antibiot
n
patient
receiv
antibiot
significantli
older
vs
year
p
correct
age
appli
group
patient
intent
antibiot
treatment
receiv
antibiot
result
receiv
exclud
analysi
remain
subset
split
group
patient
receiv
antibiot
n
n
patient
receiv
antibiot
significantli
older
vs
year
p
correct
age
appli
tabl
local
isol
procedur
respiratori
pathogen
adult
recommend
isol
patient
infect
virus
atyp
bacteria
pneumonia
c
pneumonia
bordetella
pertussi
mycobacterium
tuberculosi
complex
consid
isol
tabl
statist
analysi
clinic
biolog
paramet
hospit
antibiot
prescript
children
select
popul
hospit
exclud
patient
hospit
intend
institut
test
result
receiv
select
popul
antibiot
prescript
exclud
patient
antibiot
prescript
intend
prescrib
test
result
receiv
procedur
adequ
appli
hospit
adult
appropri
place
isol
fa
result
deliv
patient
isol
initi
plan
isol
base
result
patient
isol
alreadi
plan
properli
isol
patient
isol
plan
appropri
isol
result
receiv
data
concern
isol
intent
miss
patient
institut
oseltamivir
prescrib
influenza
posit
patient
present
symptom
sinc
less
h
either
one
comorbid
mention
inclus
criteria
regardless
comorbid
children
born
prematur
age
month
hospit
adult
pregnant
women
impact
posit
fa
result
influenza
b
virus
prescript
oseltamivir
report
tabl
oseltamivir
institut
patient
posit
influenza
test
result
indic
influenza
test
posit
yet
avoid
patient
neg
influenza
test
result
total
estim
avoid
financi
wast
euro
us
dollar
children
subset
patient
lumbar
punctur
lp
intend
prior
recept
result
split
underw
test
n
n
two
group
compar
signific
differ
observ
concern
prescript
antibiot
children
underw
lp
often
antibiot
prescrib
vs
p
signific
differ
observ
paramet
notabl
includ
posit
fa
result
inde
patient
undergo
lp
posit
fa
result
vs
undergo
lp
p
adult
patient
statist
analysi
could
perform
two
intend
lp
one
perform
emerg
room
test
order
avoid
ancillari
test
lp
minim
urinalysi
intend
blood
cultur
intend
chest
radiograph
intend
also
avoid
evalu
impact
ancillari
test
prescript
patient
admit
er
list
number
blood
sampl
urinalysi
blood
cultur
respiratori
sampl
microbiolog
sampl
urinalysi
blood
cultur
respiratori
sampl
chest
radiograph
ancillari
test
aforement
per
day
hospit
data
avail
compar
number
patient
posit
neg
fa
result
adult
signific
differ
children
admit
intens
care
er
exclud
analysi
transfer
anoth
hospit
access
clinic
data
avail
multiplex
molecular
techniqu
detect
respiratori
virus
allow
deliveri
test
result
time
manner
howev
techniqu
yet
clearli
shown
costeffect
report
result
prospect
intervent
studi
includ
select
adult
pediatr
patient
attend
emerg
room
tertiari
care
hospit
influenza
epidem
goal
analyz
whether
fa
result
influenc
patient
manag
term
antibiot
antivir
prescript
ancillari
test
prescript
admiss
length
stay
isol
found
paramet
significantli
associ
hospit
antibiot
prescript
mainli
high
white
blood
cell
count
crp
level
blood
cultur
urinalysi
perform
search
bacteri
infect
diagnosi
infect
sign
respiratori
distress
also
associ
hospit
antibiot
prescript
adult
children
differ
could
explain
fact
respiratori
distress
adult
occur
mainli
patient
decompens
chronic
obstruct
pulmonari
diseas
often
caus
infect
children
respiratori
distress
mainli
encount
bronchiol
decompens
asthma
condit
systemat
impli
antibiot
prescript
hospit
symptom
improv
follow
aerosol
treatment
emerg
room
correct
age
appli
children
concern
admiss
adult
concern
admiss
antibiot
prescript
find
indic
younger
age
children
associ
higher
admiss
rate
older
age
adult
higher
admiss
rate
antibiot
prescript
explain
children
month
age
attend
emerg
room
consist
hospit
accord
local
manag
algorithm
repres
includ
children
howev
hospit
patient
still
significantli
younger
nonhospit
one
even
remov
subset
patient
age
month
calcul
year
old
vs
p
statist
analys
compar
hospit
statu
prescript
antibiot
show
signific
differ
patient
posit
fa
result
patient
neg
result
could
explain
fact
virolog
result
crucial
manag
algorithm
inde
guidelin
regard
patient
manag
communityacquir
pneumonia
state
detect
viru
respiratori
sampl
make
bacteri
infect
less
like
provid
clinic
biolog
radiograph
sign
infect
bradley
et
al
woodhead
et
al
antibiot
prescript
necessari
institut
reli
associ
intraven
ampicillin
cefotaxim
children
month
old
children
month
old
cefotaxim
alon
prescrib
system
infect
cefuroxim
respiratori
infect
adult
respiratori
infect
treat
cefuroxim
amoxicillinclavulan
acid
administr
intraven
oral
depend
sever
symptom
antibiot
maintain
least
h
hospit
patient
reevalu
base
evolut
symptom
result
microbiolog
blood
analysi
impact
fa
result
antibiot
discontinu
hospit
patient
would
need
evalu
kesk
et
al
observ
addit
provid
rapid
molecular
test
result
offer
train
session
physician
diagnosi
manag
respiratori
tract
infect
could
decreas
antibiot
use
least
children
studi
find
differ
antibiot
use
test
adult
pediatr
patient
molecular
techniqu
hern
et
al
roger
et
al
andrew
et
al
semret
et
al
trabattoni
et
al
howev
pediatr
studi
report
shorter
antimicrobi
treatment
durat
roger
et
al
schulert
et
al
studi
result
molecular
test
deliv
time
manner
explain
lack
impact
initi
prescript
antimicrobi
treatment
even
though
impact
durat
durat
antimicrobi
treatment
record
studi
children
discharg
hospit
significantli
often
posit
fa
result
influenza
b
children
admit
hospit
signific
differ
children
posit
influenza
b
result
less
often
urinalysi
perform
children
neg
influenza
b
result
vs
p
mean
possibl
less
suspect
urinari
tract
infect
studi
also
report
trend
toward
lower
rate
admiss
adult
patient
influenza
test
posit
molecular
techniqu
comparison
convent
method
rappo
et
al
trabattoni
et
al
contribut
fa
result
patient
isol
depend
manag
algorithm
previous
describ
fa
result
impact
isol
children
children
proven
suspect
contagi
infecti
process
kept
isol
nevertheless
rapid
deliveri
fa
result
allow
better
manag
hospit
children
cohort
individu
room
avail
everi
patient
delay
emerg
room
admiss
record
shorten
accord
pediatrician
involv
studi
adult
screen
patient
molecular
techniqu
broad
panel
detect
pathogen
trigger
isol
avoid
approach
albeit
expens
permit
better
applic
isol
procedur
like
diminish
nosocomi
spread
respiratori
viral
pathogen
shown
underappreci
caus
morbid
mortal
hospit
patient
gilca
et
al
chow
mermel
appropri
prescript
oseltamivir
alreadi
report
author
xu
et
al
mitchel
et
al
studi
oseltamivir
could
confid
avoid
case
fa
neg
influenza
result
save
approxim
euro
result
also
commun
oseltamivir
prescrib
case
remind
institut
howev
total
expens
util
fa
test
approxim
euro
use
sensit
specif
molecular
techniqu
target
influenza
b
might
costeffect
option
adult
popul
trabattoni
et
al
et
al
moreov
detect
virus
influenza
seem
low
impact
hospit
adult
patient
manag
semret
et
al
techniqu
detect
broader
panel
pathogen
might
suitabl
immunosuppress
patient
notabl
hematopoiet
stem
cell
transplant
recipi
virus
influenza
treat
boeckh
semret
et
al
concern
spare
ancillari
test
er
minim
could
explain
sinc
er
manag
involv
empir
test
order
delay
triag
would
expect
posit
fa
result
could
explain
clinic
symptom
patient
thu
limit
investig
adult
patient
admit
er
paradox
observ
blood
sampl
blood
cultur
taken
patient
posit
fa
result
children
opposit
observ
less
blood
sampl
blood
cultur
microbiolog
sampl
taken
group
posit
fa
result
hypothesi
would
admit
adult
viral
infect
like
alreadi
complic
infect
children
respiratori
virus
might
probabl
respons
clinic
symptom
complic
requir
analysi
could
less
frequent
howev
find
would
requir
evalu
order
appreci
possibl
confound
paramet
studi
evalu
costeffect
multiplex
molecular
techniqu
respiratori
virus
deliv
test
result
time
frame
compar
studi
three
identifi
last
year
firstli
studi
rappo
et
al
found
lower
antimicrobi
use
fewer
chest
radiograph
order
shorter
length
stay
patient
posit
influenza
accord
fa
comparison
convent
method
differ
signific
regardless
viru
correct
age
immunosuppress
statu
asthma
intens
care
unit
admiss
reflect
import
target
popul
test
howev
rappo
et
al
studi
manag
adult
patient
two
consecut
winter
season
type
design
notabl
add
bia
interpret
data
due
differ
circul
virus
possibl
chang
manag
algorithm
two
season
secondli
studi
trabattoni
et
al
evalu
adult
patient
visit
er
test
rapid
molecular
techniqu
influenza
comparison
convent
method
also
report
fewer
radiograph
biolog
test
order
fewer
admiss
shorter
length
stay
emerg
room
group
test
molecular
techniqu
howev
group
test
convent
method
older
show
comorbid
thirdli
et
al
prospect
studi
children
adult
visit
emerg
room
acut
respiratori
tract
infect
compar
patient
test
immunofluoresc
assay
test
fa
demonstr
decreas
antibiot
prescript
adult
children
decreas
antivir
prescript
adult
decreas
ancillari
test
prescript
children
fa
group
advantag
evalu
comparison
studi
prospect
design
inclus
select
children
adult
visit
emerg
depart
epidem
season
use
standard
care
everi
patient
deliveri
test
result
patient
still
emerg
depart
major
studi
test
result
taken
consider
confound
factor
might
miss
studi
clinic
paramet
also
taken
account
analysi
provid
rapid
molecular
result
filmarray
respiratori
panel
seem
impact
hospit
decis
length
stay
initi
antibiot
ancillari
test
prescript
select
children
adult
patient
visit
emerg
room
hospit
paramet
appear
consist
account
hospit
decis
antibiot
prescript
crp
level
white
blood
cell
count
suspect
proven
bacteri
infect
adult
patient
sign
respiratori
distress
children
younger
age
also
associ
higher
admiss
rate
could
explain
local
manag
algorithm
adult
patient
older
age
associ
higher
admiss
antibiot
prescript
rate
one
except
influenza
bposit
result
lead
significantli
higher
rate
discharg
children
suggest
use
sensit
molecular
techniqu
target
influenza
b
could
costeffect
set
posit
impact
use
filmarray
respiratori
panel
might
import
highrisk
popul
immunosuppress
patient
influenza
virus
treat
would
possibl
avoid
detriment
outcom
train
session
physician
diagnosi
manag
respiratori
tract
infect
could
improv
impact
benefit
result
use
fa
addit
adequ
prescript
oseltamivir
hard
apprais
make
costbenefit
calcul
difficult
benefit
mainli
faster
better
implement
isol
algorithm
hospit
patient
probabl
result
decreas
nosocomi
infect
point
well
contribut
molecular
test
result
avoid
ancillari
test
discontinu
antibiot
patient
hospit
need
evalu
none
studi
approv
ethic
committe
univers
hospit
saint
pierr
brussel
refer
